Under construction – not a live service
Sign in
TerminatedNo phase

BOBBY™ Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke

Key facts

Who runs it
Microvention-Terumo, Inc.
Where
Germany and Switzerland9 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Terminated
People taking part
171 people enrolled
Started
8 Apr 2022
Ended
30 Dec 2023
Type of study
Observational
Treatments tested
  • BOBBY™ Balloon Guide Catheter intended for use in neurovascular procedures, performing or as an adjunctive device
Record updated
7 January 2025
Why it stopped
endpoint reached

Who can take part

Age
18 years to 85 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Patient is ≥ 18 and ≤ 85 years of age
  • Informed consent by the patient or legal authorized representative for data collection is obtained
  • Patient eligible for the mechanical thrombectomy treatment with adjunctive use of the BOBBY™ BGC
  • Patient presenting with an anterior circulation large-vessel occlusion of distal internal carotic artery (ICA ) through proximal M2 confirmed by computed tomograph angiography (CTA), magnetic resonance angiography (MRA), or digital subtraction angiography (DSA)
  • Core-infarct volume of Alberta Stroke Program Early CT Score (ASPECTS) ≥ 6 based on baseline CT or MR imaging
  • Treatment initiated (groin puncture) within 8 hours of symptom onset
  • Patient with a pre-treatment National Institutes of Health Stroke Scale (NIHSS) score ≥5
  • Patient with no personal condition disabling the site to contact him/her at 90 days after procedure

Who cannot take part

  • Patient is already participating in an investigational drug or device trial (change routine care of the patient)
  • Patient presents other serious medical illness (e.g., cancer) with estimated life expectancy of less than 3 months
  • Patient has evidence of intracerebral hemorrhage on initial imaging
  • Patient has evidence of cerebral ischemia in the posterior circulation
  • Patient presents severe unilateral or bilateral carotid artery stenosis requiring stent treatment during the procedure
  • Pregnancy or breastfeeding
  • Patient has a planned procedure that may cause non-compliance with the protocol or confound data interpretation
  • Patient has a significant mass effect with midline shift

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Evaluation of the safety and performance of the BOBBY™ Balloon Guide Catheter (BGC) in patients with an acute ischemic stroke treatment, a sudden reduction or termination of the blood circulation of the brain, caused by a clot. Immediate treatment is needed to restore the blood circulation in the brain, performing a mechanical removal of the clot (thrombectomy). To prevent clot particles migrating in other parts of the brain circulation during the thrombectomy, balloon guiding catheters are inserted. The aim of the study is to evaluate the safety and performance of the balloon guide catheter BOBBY™ by collecting information from patients, treated with a mechanical thrombectomy and the balloon guide catheter (BOBBY™) after acute ischemic stroke

The group in the trial

  • single arm, observational post market study

    Patients with an acute ischemic stroke with treatment including the BOBBY™ BGC

    Treatment: BOBBY™ Balloon Guide Catheter intended for use in neurovascular procedures, performing or as an adjunctive device

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
STRAIT: Evaluation of Safety and Performance of the BOBBY™ Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke
Publications
Record updated
7 January 2025